Stephen J. Bagley et al.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Nature Cancer 2024
doi: 10.1038/s43018-023-00709-6